Abstract:Current evidence suggests that the the neutrophil/lymphocyte ratio (NLR) is growing as a prognostic marker in patient with cardiovascular disease. It has been reported expanding evidence that involves innate and adaptive immune cell in the pathogenesis of Acute Coronary syndrome (ACS) which indicate the pivotal role of NLR as valuable diagnostic parameter in ACS patient. Purpose: The objective of our meta-analysis is to investigate the association of neutrophil lymphocyte ratio (NLR) for ACS risk and the prognostic utility of NLR in ACS patients. We conducted a systematic literature search on various databases such as PubMed, Cochrane and Scopus to identify the relevant articles published until October 2021. Data extracted were pooled using odds ratios (OR) for incidence of ACS and non- ACS patients between high and low NLR. For studies that did not provide these estimates, data were extracted using weighted mean difference (WMD) of NLR for ACS and non-ACS patients. A random effects model was used to conduct this MA. The receiver operating characteristic (ROC) curve was utilized to analyze the prognostic ability of NLR in the ACS patients. Heterogeneity was evaluate using Cochran's Q- and the I 2 − test. GRADE was used to assess the study's quality. The presence of publication bias was evaluated by Egger's test and by visual inspection of the symmetry in funnel plots. Data analysis was conducted using Stata. Nine studies met the inclusion criteria with more than 5215 participants. The MA that used OR as effect size was 1.44 (95% CI:1.082–1.92) with low heterogeneity (Chi- square = 6.2; P-value = 0,0012 I2 = 12.8%). The analyze that used WMD as effect size was 1.24 (95% CI: 1.04- 1.43) with high heterogeneity (Chi-square = 102.7; P-value < 0.001 I2 = 95.1%). There was no evidence of publication bias from Egger's test for OR effect size MA and for WMD MA (coefficient = 0.58; P-value = 0.558) and (coefficient = 3.06; P-value = 0.361). The ROC curve shows that AUC (ACS) = 88.8% (95% CI:0.73 – 1). The best cut- off point of the N/L was 4, with a sensitivity of 82.8 % and a specificity of 77.7 % The MA that used OR as effect size indicated high NLR was significantly associated with increased risk of ACS. The analyze that used WMD as effect size indicated mean NLR was significantly higher in ACS patients than in non-ACS patients. ROC curve analysis was significant for NLR in diagnosing ACS. Therefore, our results conclude that the NLR effect was strongest on ACS outcome and might also help in early diagnosis of ACS and all this make NLR a predictive biomarker in ACS patient .

Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases

Progress in the Application of the Neutrophil-to-lymphocyte Ratio in Dialysis-Related Complications

Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients

Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond

Neutrophil-to-Lymphocyte Ratio in Adult Community-Acquired Pneumonia Patients Correlates with Unfavorable Clinical Outcomes

PS-BPB02-7: THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AS PREDICTIVE BIOMARKER IN ACUTE CORONARY SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS

A Review of the Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Nonhematologic Malignancies

Neutrophil-to-lymphocyte Ratio as a Marker for Diagnosis and Prognostication of Sepsis

Neutrophil-to-lymphocyte ratio and mortality in the United States general population

The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study

Could a simple biomarker as neutrophil-to-lymphocyte ratio reflect complex processes orchestrated by neutrophils?

A Comprehensive Systematic Review and Meta-Analysis of the Association between the Neutrophil-to-Lymphocyte Ratio and Adverse Outcomes in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

The Neutrophil-Lymphocyte Ratio: A Promising Predictor of Mortality in Coronary Care Unit Patients - A Cohort Study

Neutrophil-to-Lymphocyte Ratio (NLR) Useful as a Cost-Effective Preliminary Prognostic Marker in ST-Elevation Myocardial Infarction (STEMI): An Observational Study From a Tertiary Care Hospital in Northeast India

Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Importance of the neutrophil-to-lymphocyte ratio as a marker for microbiological specimens in critically ill patients after liver or lung transplantation

Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease

Neutrophil to Lymphocyte Ratio As Prognostic and Predictive Factor in Patients with Coronavirus Disease 2019: A Retrospective Cross-Sectional Study.

The Prognostic Values of Neutrophil to Lymphocyte Ratio for Outcomes in Chronic Obstructive Pulmonary Disease

The Prognostic Role of the Neutrophil-to-Lymphocytes Ratio in the Most Frequent Cardiovascular Diseases: An Update

A meta-analysis of the clinical significance of neutrophil-to-lymphocyte ratios in interstitial lung disease